Windlas Biotech reported Q3 FY25 earnings with revenues reaching INR195 crores, a 20% year-on-year increase, and total revenues for 9 months at INR557.2 crores, demonstrating a 21% growth. EBITDA is up 22% year-on-year to INR68.6 crores, showing strong performance across its business segments.